Journal
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
Volume 12, Issue 9, Pages 1021-1023Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1586/14787210.2014.950229
Keywords
cervical cancer; HIV; HPV; protease inhibitors; therapy
Ask authors/readers for more resources
Over the past decade it has been demonstrated that HIV protease inhibitors have various off-target activities that has enabled them to be repositioned as treatments for a range of other pathologies. Human papilloma virus and related malignancies have been shown to be susceptible to these agents and current progress with this indication is summarized here together with a discussion of the rationale for the off-target effects of these compounds.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available